Description

MCC-Modified Daunorubicinol is a drug-Linker conjugates for ADC, which is composed of Modified Daunorubicinol (DNA topoisomerase II inhibitor) and MCC (ADC linker) linked[1].–Applications-Cancer-programmed cell death-Formula-C39H44N4O13-Citation–References-[1]Samantha Congreve, et al. Antibody drug conjugates (ADC) Current status and mapping of ADC:s in clinical programs.-CASNumber-721945-30-8-MolecularWeight-776.79-Compound Purity–SMILES-N[C@H]([C@H](O)[C@H](C)O1)C[C@]1([H])O[C@@H]2C3=C(C[C@](/C(CO)=N/NC(C4CCC(CN5C(C=CC5=O)=O)CC4)=O)(O)C2)C(O)=C6C(C(C7=C(OC)C=CC=C7C6=O)=O)=C3O-Research_Area-Cancer-Solubility-10 mM in DMSO-Target-Drug-Linker Conjugates for ADC-Isoform-Daunorubicins/Doxorubicins-Pathway-Antibody-drug Conjugate/ADC Related-MCE Product type-ADC Related